Skip to content
Cryptos: 553Market Cap: $2.87T 1.3%24h Vol: $129.14BDominance: BTC 58.1% ETH 10.5%
Open Tradzy

New high · Germany stocks

Takeda Pharmaceutical Company Limited (TKDA) closes at a 11-month high of €17.40

Its fourth new 11-month high in 5 sessions. Up 6.7% over 20 sessions.

Published 16 October 2026 · Written from Tradzy's price and volume data

Close
€17.40
On the day
+0.6%
Volume
no average yet
vs 11-month high
New high

Takeda Pharmaceutical Company Limited closing prices

€14.00€16.00Jun '26Jul '26Aug '26Aug '26Sep '26Oct '26€17.40

The last 90 closes up to 16 October 2026. The live chart is on the TKDA page.

What happened

Takeda Pharmaceutical Company Limited (TKDA) closed at €17.40 on 16 October 2026, up 0.6% from €17.30 the session before.

It was the third higher close in a row. It is the fourth new high in the last 5 sessions. Over 5 sessions the price is up 4.8%, and over 20 sessions it is up 6.7%.

That close is above every close of the past 11 months. The previous highest was €17.30 on 15 Oct 2026, and the new close is 0.6% above it.

Across the 5 STUTTGART stocks we track, 2 closed higher and 1 closed lower that day, with a median change of 0.00%. TKDA's change was +0.6%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous close€17.30
Close€17.40
Change on the day+0.58%
Change over 5 sessions+4.82%
Change over 20 sessions+6.75%
Volumenot reported
Average volume, up to 20 sessions beforenot enough history
Volume against that averagenot enough history
Highest close in the past 11 months€17.30 (15 Oct 2026)
Lowest close in the past 11 months€11.60 (5 Nov 2025)

The full chart and history are on Takeda Pharmaceutical Company Limited (TKDA). More from this market: STUTTGART news today.

More STUTTGART moves on 16 October 2026

Want a plan for TKDA? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.